Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-14-000253

CEO, PRESIDENT acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jaksch Frank L Jr · CEO, PRESIDENT

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2014-01-21 Grant or award : show line 1 in the form +250,000 589,165 D
Loading xslF345X03/form4-01232014_050137.xml…